205 related articles for article (PubMed ID: 3882233)
1. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
[No Abstract] [Full Text] [Related]
2. Treatment of metastatic sarcomas with mitoxantrone.
Presant CA; Gams R; Bartolucci AA
Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
[No Abstract] [Full Text] [Related]
3. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Birch R
Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Gams RA; Nelson O; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
[No Abstract] [Full Text] [Related]
6. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
Thigpen JT; Samson MK
Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
[No Abstract] [Full Text] [Related]
7. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
8. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
[No Abstract] [Full Text] [Related]
9. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
Chan C; Bartolucci A; Brenner D; Presant C; Davila E; Carpenter J; Greco FA; Clamon G; Moore J
Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
[No Abstract] [Full Text] [Related]
10. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
Sordillo PP; Magill GB; Gralla RJ; Golbey RB
Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
[No Abstract] [Full Text] [Related]
11. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
[No Abstract] [Full Text] [Related]
12. Phase II trial of mitoxantrone in advanced colorectal cancer.
Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
[No Abstract] [Full Text] [Related]
13. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
DeSimone PA; Gams R; Bartolucci A
Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
[No Abstract] [Full Text] [Related]
14. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
[TBL] [Abstract][Full Text] [Related]
15. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
[No Abstract] [Full Text] [Related]
16. Potential cardiotoxicity with mitoxantrone.
Schell FC; Yap HY; Blumenschein G; Valdivieso M; Bodey G
Cancer Treat Rep; 1982 Aug; 66(8):1641-3. PubMed ID: 7105054
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study.
Thigpen JT; Vaughn C; Stuckey WJ
Cancer Treat Rep; 1981; 65(9-10):881-2. PubMed ID: 7273022
[No Abstract] [Full Text] [Related]
18. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
Williams SD; Birch R; Gams R; Irwin L
Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
[No Abstract] [Full Text] [Related]
19. Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.
Alberts DS; Balcerzak SP; Bonnet JD; Stephens RL
Cancer Treat Rep; 1985 Nov; 69(11):1321-3. PubMed ID: 4092195
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
